Cargando…

The therapeutic potential of Camel Wharton jelly mesenchymal stem cells (CWJ-MSCs) in canine chronic kidney disease model

BACKGROUND: Chronic kidney disease (CKD) is a worldwide health problem that its incidence increases nowadays with the increase in the risk of environmental pollution. CKD can progress to end-stage renal disease (ESRD) which usually ends fatally. This study aimed to examine the therapeutic potential...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Miniawy, Hala M. F., Farghali, Haithem A., Khattab, Marwa S., Emam, Ibrahim A., Ibrahem, Essam M., Sabry, Dina, Ismail, Tahany A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338563/ https://www.ncbi.nlm.nih.gov/pubmed/35908006 http://dx.doi.org/10.1186/s13287-022-03076-8

Ejemplares similares

Mechanisms of Wharton’s Jelly-derived MSCs in enhancing peripheral nerve regeneration
por: Shin, Young Ho, et al.
Publicado: (2023)

In vivo antitumour potential of camel’s milk against hepatocellular carcinoma in rats and its improvement of cisplatin renal side effects
por: El Miniawy, Hala M. F., et al.
Publicado: (2017)

Molecular and Functional Verification of Wharton’s Jelly Mesenchymal Stem Cells (WJ-MSCs) Pluripotency
por: Musiał-Wysocka, Aleksandra, et al.
Publicado: (2019)

Cardioprotective Effects of Wharton Jelly Derived Mesenchymal Stem Cell Transplantation in a Rodent Model of Myocardial Injury
por: Gaafar, Taghrid, et al.
Publicado: (2017)

The anti-inflammatory effect of myrrh ethanolic extract in comparison with prednisolone on an autoimmune disease rat model induced by silicate
por: ElMosbah, Dina E., et al.
Publicado: (2022)

The Treasury of Wharton's Jelly
por: Guenther, Rebecca, et al.
Publicado: (2021)

Comparison of Explant-Derived and Enzymatic Digestion-Derived MSCs and the Growth Factors from Wharton's Jelly
por: Yoon, Jong Hyun, et al.
Publicado: (2013)

Comparison of human isogeneic Wharton’s jelly MSCs and iPSC-derived MSCs reveals differentiation-dependent metabolic responses to IFNG stimulation
por: Devito, Liani, et al.
Publicado: (2019)

Biomimetic microenvironmental preconditioning enhance neuroprotective properties of human mesenchymal stem cells derived from Wharton's Jelly (WJ-MSCs)
por: Lech, Wioletta, et al.
Publicado: (2020)

Therapeutic Potential of Wharton’s Jelly Mesenchymal Stem Cells for Diabetes: Achievements and Challenges
por: Kamal, Mohamed M., et al.
Publicado: (2020)

The effects of human Wharton’s jelly cell transplantation on the intervertebral disc in a canine disc degeneration model
por: Zhang, Yan, et al.
Publicado: (2015)

Cell Therapy with Human MSCs Isolated from the Umbilical Cord Wharton Jelly Associated to a PVA Membrane in the Treatment of Chronic Skin Wounds
por: Ribeiro, Jorge, et al.
Publicado: (2014)

Decellularization of Wharton’s Jelly Increases Its Bioactivity and Antibacterial Properties
por: Dubus, M., et al.
Publicado: (2022)

Wharton’s jelly absence: a possible cause of stillbirth
por: Damasceno, Eduarda Bittencourt, et al.
Publicado: (2013)

Antibacterial and Immunomodulatory Properties of Acellular Wharton’s Jelly Matrix
por: Dubus, Marie, et al.
Publicado: (2022)

An Injectable Hyaluronan–Methylcellulose (HAMC) Hydrogel Combined with Wharton’s Jelly-Derived Mesenchymal Stromal Cells (WJ-MSCs) Promotes Degenerative Disc Repair
por: Choi, Un Yong, et al.
Publicado: (2020)

Effects of maternal obesity on Wharton’s Jelly mesenchymal stromal cells
por: Badraiq, Heba, et al.
Publicado: (2017)

The Immunomodulatory Potential of Wharton's Jelly Mesenchymal Stem/Stromal Cells
por: Vieira Paladino, Fernanda, et al.
Publicado: (2019)

AFM-based Analysis of Wharton’s Jelly Mesenchymal Stem Cells
por: Szydlak, Renata, et al.
Publicado: (2019)

Umbilical cord-derived Wharton’s jelly for regenerative medicine applications
por: Gupta, Ashim, et al.
Publicado: (2020)

Corneal Ulcer in Dogs and Cats: Novel Clinical Application of Regenerative Therapy Using Subconjunctival Injection of Autologous Platelet-Rich Plasma
por: Farghali, Haithem A., et al.
Publicado: (2021)

Novel approach to gastric mucosal defect repair using fresh amniotic membrane allograft in dogs (experimental study)
por: Farghali, Haithem A., et al.
Publicado: (2017)

Evaluation of subcutaneous infiltration of autologous platelet-rich plasma on skin-wound healing in dogs
por: Farghali, Haithem A., et al.
Publicado: (2017)

Exendin-4 enhances the differentiation of Wharton’s jelly mesenchymal stem cells into insulin-producing cells through activation of various β-cell markers
por: Kassem, Dina H., et al.
Publicado: (2016)

Proteome analysis of human Wharton's jelly cells during in vitro expansion
por: Angelucci, Stefania, et al.
Publicado: (2010)

Wharton's jelly mesenchymal stem cells differentiate into retinal progenitor cells
por: Hu, Ying, et al.
Publicado: (2013)

Effects of Wharton’s jelly-derived mesenchymal stem cells on neonatal neutrophils
por: Khan, Imteyaz, et al.
Publicado: (2014)

Differentiation of Wharton's jelly mesenchymal stem cells into neurons in alginate scaffold
por: Hosseini, Seyed Mojtaba, et al.
Publicado: (2015)

Wharton’ jelly mesenchymal stromal cell therapy for ischemic brain injury
por: Wu, Kuo-Jen, et al.
Publicado: (2018)

Perinatal sources of mesenchymal stem cells: Wharton’s jelly, amnion and chorion
por: Witkowska-Zimny, Malgorzata, et al.
Publicado: (2011)

Abstract 126: Wharton’s Jelly Induces Osteogenesis In An Alveolar Cleft Model
por: Greives, Matthew R., et al.
Publicado: (2017)

Acellular Wharton’s Jelly, Potentials in T-Cell Subtypes Differentiation, Activation and Proliferation
por: Talebi, Mehdi, et al.
Publicado: (2020)

Isolation and Characterization of Feline Wharton’s Jelly-Derived Mesenchymal Stem Cells
por: Seo, Min-Soo, et al.
Publicado: (2021)

The Molecular Regulatory Mechanism in Multipotency and Differentiation of Wharton’s Jelly Stem Cells
por: Ma, Li, et al.
Publicado: (2023)

Decreased Inhibition of Proliferation and Induction of Apoptosis in Breast Cancer Cell Lines (T47D and MCF7) from Treatment with Conditioned Medium Derived from Hypoxia-Treated Wharton’s Jelly MSCs Compared with Normoxia-Treated MSCs
por: Widowati, Wahyu, et al.
Publicado: (2021)

Umbilical Cord-Derived Wharton’s Jelly for Regenerative Medicine Applications: A Systematic Review
por: Main, Benjamin J., et al.
Publicado: (2021)

Wharton’s jelly mesenchymal stem cells promote wound healing and tissue regeneration
por: Kamolz, Lars-Peter, et al.
Publicado: (2014)

Wharton's Jelly human Mesenchymal Stem Cell contact guidance by noisy nanotopographies
por: Jacchetti, E., et al.
Publicado: (2014)

Concise Review: Wharton's Jelly: The Rich, but Enigmatic, Source of Mesenchymal Stromal Cells
por: Davies, John E., et al.
Publicado: (2017)

Porcine Wharton’s jelly cells distribute throughout the body after intraperitoneal injection
por: Packthongsuk, Kreeson, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t6c8t2q4jetkk0l9iu4a7h6hkc